1. Home
  2. RPHM vs FLNT Comparison

RPHM vs FLNT Comparison

Compare RPHM & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • FLNT
  • Stock Information
  • Founded
  • RPHM 2014
  • FLNT 2010
  • Country
  • RPHM United States
  • FLNT United States
  • Employees
  • RPHM N/A
  • FLNT N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • FLNT Advertising
  • Sector
  • RPHM Health Care
  • FLNT Consumer Discretionary
  • Exchange
  • RPHM Nasdaq
  • FLNT Nasdaq
  • Market Cap
  • RPHM 47.5M
  • FLNT 44.7M
  • IPO Year
  • RPHM 2021
  • FLNT N/A
  • Fundamental
  • Price
  • RPHM N/A
  • FLNT $3.01
  • Analyst Decision
  • RPHM Hold
  • FLNT Hold
  • Analyst Count
  • RPHM 6
  • FLNT 1
  • Target Price
  • RPHM $2.26
  • FLNT $4.00
  • AVG Volume (30 Days)
  • RPHM 345.4K
  • FLNT 24.8K
  • Earning Date
  • RPHM 11-11-2024
  • FLNT 11-12-2024
  • Dividend Yield
  • RPHM N/A
  • FLNT N/A
  • EPS Growth
  • RPHM N/A
  • FLNT N/A
  • EPS
  • RPHM N/A
  • FLNT N/A
  • Revenue
  • RPHM N/A
  • FLNT $263,700,000.00
  • Revenue This Year
  • RPHM N/A
  • FLNT N/A
  • Revenue Next Year
  • RPHM N/A
  • FLNT $13.16
  • P/E Ratio
  • RPHM N/A
  • FLNT N/A
  • Revenue Growth
  • RPHM N/A
  • FLNT N/A
  • 52 Week Low
  • RPHM $1.68
  • FLNT $2.31
  • 52 Week High
  • RPHM $92.10
  • FLNT $4.80
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 18.64
  • FLNT 48.40
  • Support Level
  • RPHM $16.10
  • FLNT $2.70
  • Resistance Level
  • RPHM $19.00
  • FLNT $3.41
  • Average True Range (ATR)
  • RPHM 0.94
  • FLNT 0.29
  • MACD
  • RPHM -1.95
  • FLNT -0.05
  • Stochastic Oscillator
  • RPHM 0.00
  • FLNT 27.44

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About FLNT Fluent Inc.

Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.

Share on Social Networks: